Spinal Muscular Atrophy: More than a Disease of Motor Neurons?

被引:75
|
作者
Nash, L. A. [1 ,2 ,3 ]
Burns, J. K. [1 ,2 ,3 ]
Chardon, J. Warman [3 ,4 ,5 ]
Kothary, R. [1 ,3 ,4 ,6 ]
Parks, R. J. [1 ,2 ,3 ,4 ]
机构
[1] Ottawa Hosp, Res Inst, Regenerat Med Program, Gen Campus Gen,501 Smyth Rd,Room C4415, Ottawa, ON K1H 8L6, Canada
[2] Univ Ottawa, Dept Biochem Microbiol & Immunol, Fac Med, Ottawa, ON, Canada
[3] Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada
[4] Univ Ottawa, Dept Med, Fac Med, Ottawa, ON, Canada
[5] Childrens Hosp Eastern Ontario, Dept Genet, Div Neurogenet, Ottawa, ON, Canada
[6] Univ Ottawa, Dept Cellular & Mol Med, Fac Med, Ottawa, ON, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
Gene therapy; motor neuron; neuromuscular disease; spinal muscular atrophy; survival of motor neuron; therapeutics; SURVIVAL MOTONEURON PROTEIN; EXONIC SPLICING ENHANCER; DETERMINING GENE-PRODUCT; PRE-MESSENGER-RNA; SMA MOUSE MODEL; NEUROMUSCULAR-JUNCTION; SCAAV9-SMN DELIVERY; GLUCOSE-METABOLISM; GROWTH CONES; DEFECTS;
D O I
10.2174/1566524016666161128113338
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Spinal muscular atrophy (SMA) is the most common genetically inherited neurodegenerative disease resulting in infant mortality. SMA is caused by genetic deletion or mutation in the survival of motor neuron 1 (SMN1) gene, which results in reduced levels of the survival of motor neuron (SMN) protein. SMN protein deficiency preferentially affects amotor neurons, leading to their degeneration and subsequent atrophy of limb and trunk muscles, progressing to death in severe forms of the disease. More recent studies have shown that SMN protein depletion is detrimental to the functioning of other tissues including skeletal muscle, heart, autonomic and enteric nervous systems, metabolic/endocrine (e.g. pancreas), lymphatic, bone and reproductive system. In this review, we summarize studies discussing SMN protein's function in various cell and tissue types and their involvement in the context of SMA disease etiology. Taken together, these studies indicate that SMA is a multi-organ disease, which suggests that truly effective disease intervention may require body-wide correction of SMN protein levels.
引用
收藏
页码:779 / 792
页数:14
相关论文
共 50 条
  • [31] Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?
    Shababi, Monir
    Lorson, Christian L.
    Rudnik-Schoeneborn, Sabine S.
    JOURNAL OF ANATOMY, 2014, 224 (01) : 15 - 28
  • [32] Improved therapeutic approach for spinal muscular atrophy via ubiquitination-resistant survival motor neuron variant
    Rhee, Joonwoo
    Kang, Jong-Seol
    Jo, Young-Woo
    Yoo, Kyusang
    Kim, Ye Lynne
    Hann, Sang-Hyeon
    Kim, Yea-Eun
    Kim, Hyun
    Kim, Ji-Hoon
    Kong, Young-Yun
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2024, 15 (04) : 1404 - 1417
  • [33] Spinal Muscular Atrophy A (Now) Treatable Neurodegenerative Disease
    Fay, Alex
    PEDIATRIC CLINICS OF NORTH AMERICA, 2023, 70 (05) : 963 - 977
  • [34] A novel zebrafish model for intermediate type spinal muscular atrophy demonstrates importance of Smn for maintenance of mature motor neurons
    Tay, Shermaine Huiping
    Ellieyana, Erna Nur
    Le, Yao
    Sarusie, Menachem Viktor
    Grimm, Clemens
    Ohmer, Jurgen
    Mathuru, Ajay S.
    Fischer, Utz
    Winkler, Christoph
    HUMAN MOLECULAR GENETICS, 2021, 30 (24) : 2488 - 2502
  • [35] Depletion and sizes of motor units in spinal muscular atrophy
    Galea, V
    Fehlings, D
    Kirsch, S
    McComas, A
    MUSCLE & NERVE, 2001, 24 (09) : 1168 - 1172
  • [36] Advances in understanding the role of disease-associated proteins in spinal muscular atrophy
    Hosseinibarkooie, Seyyedmohsen
    Schneider, Svenja
    Wirth, Brunhilde
    EXPERT REVIEW OF PROTEOMICS, 2017, 14 (07) : 581 - 592
  • [37] Spinal muscular atrophy: An update on therapeutic progress
    Seo, Joonbae
    Howell, Matthew D.
    Singh, Natalia N.
    Singh, Ravindra N.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2013, 1832 (12): : 2180 - 2190
  • [38] Investigational therapies for the treatment of spinal muscular atrophy
    Kaczmarek, Anna
    Schneider, Svenja
    Wirth, Brunhilde
    Riessland, Markus
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (07) : 867 - 881
  • [39] Severe ketoacidosis in a patient with spinal muscular atrophy
    Lakkis B.
    El Chediak A.
    Hashash J.G.
    Koubar S.H.
    CEN Case Reports, 2018, 7 (2) : 292 - 295
  • [40] Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
    Burghes, Arthur H. M.
    Beattie, Christine E.
    NATURE REVIEWS NEUROSCIENCE, 2009, 10 (08) : 597 - 609